多模式患者数据的综合分析确定了结核病治疗预后的个性化预测因素
Awanti Sambarey1, Kirk Smith1, Carolina Chung1
1Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
iScience
|February 15, 2024
概括
预测结核病 (TB) 治疗成功至关重要. 一个使用来自5,060名患者的多域数据的机器学习模型准确地确定了个性化结核病管理的关键预测因素.
科学领域:
- 传染性疾病 传染性疾病
- 计算生物学 计算生物学
- 临床医学 临床医学
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,多抗药性 (MDR-TB) 和广泛抗药性 (XDR-TB) 菌株的发病率不断增加.
- 有效的治疗策略受到结核病的复杂性和需要个性化的方法的阻碍.
研究的目的:
- 通过使用全面的多领域数据集,识别结核病治疗结果的预测因素.
- 开发和评估用于预测结核病治疗成功的机器学习模型.
主要方法:
- 通过使用NIAID结核病门户数据库,分析了来自10个高负担国家的5,060名结核病患者的多领域数据 (放射学,微生物学,治疗,人口学).
- 开发一个机器学习模型,结合203个特征来预测治疗结果.
- 使用精度和曲线下的面积 (AUC) 评估模型性能.
主要成果:
- 机器学习模型实现了83%的准确性和0.84的AUC,优于基于单个数据模式的模型.
- 在放射性,微生物学,治疗性和人口因素与结核病治疗结果之间发现了显著的关联.
- 确定了特定的药物方案,如Bedaquiline-Clofazimine-Cycloserine-Levofloxacin-Linezolid (与成功相关) 和Bedaquiline-Clofazimine-Linezolid-Moxifloxacin (与失败相关) 用于MDR非XDR-TB. 由INDIGO算法预测的协同药物组合显示出更好的结果.
结论:
- 多领域机器学习方法有效预测结核病治疗结果.
- 功能优先级为结核病患者的个性化临床管理提供了洞察力,特别是那些具有耐药菌株的结核病患者.
- 确定最佳药物治疗方案和理解预测变量对于改善结核病治疗成功率至关重要.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
相关概念视频
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis III
326
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
326
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
